APA

Takenaka T., Mikuni C., Miura A., Sasaki T., Suzuki H., Hotta T., Hirano M., Fukuhara S., Sugiyama H., Nasu K., Dohi H., Kozuru M., Tomonaga M., Tajima K., Niimi M., Fukuda H., Mukai K. & Shimoyama M. (20000522). Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

Chicago

Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K and Shimoyama M. 20000522. Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

Harvard

Takenaka T., Mikuni C., Miura A., Sasaki T., Suzuki H., Hotta T., Hirano M., Fukuhara S., Sugiyama H., Nasu K., Dohi H., Kozuru M., Tomonaga M., Tajima K., Niimi M., Fukuda H., Mukai K. and Shimoyama M. (20000522). Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

MLA

Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K and Shimoyama M. Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology. 20000522.